Feedback-regulated DDS MCQs With Answer

Feedback-regulated DDS MCQs With Answer

This quiz collection is designed for M.Pharm students studying Novel Drug Delivery Systems, focusing on feedback-regulated drug delivery systems (DDS). It covers fundamental principles, sensing modalities, control strategies, material platforms and clinical applications of closed‑loop DDS — for example, glucose‑responsive insulin patches or implantable pumps with biometric feedback. Questions probe mechanisms such as enzyme‑ or ligand‑responsive materials, biosensor integration, feedback control algorithms, pharmacokinetic/pharmacodynamic considerations, safety and regulatory aspects. Use these MCQs to deepen conceptual understanding and prepare for exams by applying theory to real‑world design challenges in smart, self‑regulating drug delivery.

Q1. What is the defining characteristic of a feedback‑regulated drug delivery system?

• Preprogrammed time‑based release independent of physiological signals
• Passive diffusion from a matrix driven solely by concentration gradients
• Closed‑loop release that adjusts drug delivery in response to a physiological signal
• Single bolus injection followed by systemic elimination

Correct Answer: Closed‑loop release that adjusts drug delivery in response to a physiological signal

Q2. Which sensing modality is most commonly used in commercial closed‑loop insulin systems for glucose measurement?

• Optical fluorescence sensor implanted subcutaneously
• Enzymatic electrochemical glucose sensor (continuous glucose monitor)
• Mass spectrometry‑based interstitial sampling
• Piezoelectric pressure sensor measuring tissue stiffness

Correct Answer: Enzymatic electrochemical glucose sensor (continuous glucose monitor)

Q3. In polymeric hydrogels used for feedback‑regulated DDS, which mechanism commonly produces reversible drug release in response to glucose?

• Hydrogel degradation by UV light
• Glucose‑binding crosslinks altering swelling (e.g., phenylboronic acid chemistry)
• Irreversible cleavage by high‑energy radiation
• Thermal melting above physiological temperature

Correct Answer: Glucose‑binding crosslinks altering swelling (e.g., phenylboronic acid chemistry)

Q4. Which of the following best describes an “aptamer‑based” feedback element in a DDS?

• A small peptide that forms the structural scaffold of a hydrogel
• A nucleic acid sequence that binds a target analyte and changes conformation to modulate release
• An inorganic nanoparticle that releases heat under magnetic field
• A biodegradable polymer that slowly erodes irrespective of analyte

Correct Answer: A nucleic acid sequence that binds a target analyte and changes conformation to modulate release

Q5. Which feedback control algorithm is most frequently cited in engineering closed‑loop DDS to reduce steady‑state error?

• On‑off controller without proportional term
• Proportional‑Integral‑Derivative (PID) controller
• Pure feedforward open‑loop schedule
• Randomized pulse delivery

Correct Answer: Proportional‑Integral‑Derivative (PID) controller

Q6. A major limitation of enzymatic glucose sensors used in feedback DDS is:

• Absolute immunity to interference from medications
• Potential signal drift and enzyme degradation over time
• Inability to detect glucose in interstitial fluid
• Unlimited lifetime without recalibration

Correct Answer: Potential signal drift and enzyme degradation over time

Q7. Which material property is critical for implantable feedback‑regulated reservoirs to minimize foreign body response and maintain sensor function?

• High surface roughness to maximize protein adsorption
• Biocompatibility and low fouling surface chemistry
• High electrical conductivity of the polymer matrix
• Rapid non‑controlled biodegradation within days

Correct Answer: Biocompatibility and low fouling surface chemistry

Q8. In glucose‑responsive insulin delivery systems using glucose oxidase, what is the primary local change that can trigger insulin release?

• Local increase in pH due to gluconic acid formation
• Immediate generation of high molecular weight polymers
• Production of oxygen gas bubbles inflating the device
• Direct covalent bonding of glucose to insulin

Correct Answer: Local increase in pH due to gluconic acid formation

Q9. Which of the following is an advantage of electronic closed‑loop DDS over purely material‑based feedback systems?

• Complete independence from power sources
• Ability to implement complex control algorithms and remote telemetry
• Zero risk of device malfunction or software bugs
• Automatic biodegradation after therapy ends

Correct Answer: Ability to implement complex control algorithms and remote telemetry

Q10. “Hysteresis” in a feedback‑regulated DDS refers to:

• The ability of the system to instantly return to baseline without delay
• The system exhibiting different output for the same input depending on prior state (lag or memory effect)
• Perfect linearity between analyte concentration and drug release rate
• Complete insensitivity to changes in physiological signals

Correct Answer: The system exhibiting different output for the same input depending on prior state (lag or memory effect)

Q11. Which pharmacokinetic factor is most important when designing a feedback‑regulated DDS for hormones with short half‑lives?

• Ability to provide rapid onset and frequent, controlled microdoses
• Preferential release of a single large bolus monthly
• Design to maximize irreversible tissue accumulation
• Maximizing drug molecular weight regardless of clearance

Correct Answer: Ability to provide rapid onset and frequent, controlled microdoses

Q12. Which strategy can be used to reduce false triggers from nonspecific analyte fluctuations in feedback DDS?

• Lowering the detection threshold to the minimum possible value
• Incorporating hysteresis or filtering and using multiple sensor modalities
• Removing any calibration and relying on raw sensor outputs
• Designing sensors that only respond to temperature changes

Correct Answer: Incorporating hysteresis or filtering and using multiple sensor modalities

Q13. An example of a biochemical feedback mechanism used in closed‑loop DDS is:

• Magnetically actuated nanoparticle heating only
• Use of antibody‑antigen binding to sequester and release a drug
• Radiation‑driven polymer degradation
• Purely mechanical squeezing of a reservoir on a fixed schedule

Correct Answer: Use of antibody‑antigen binding to sequester and release a drug

Q14. For a glucose‑responsive insulin patch using phenylboronic acid chemistry, the primary sensing transduction is:

• Reversible covalent binding to diols causing hydrogel swelling or deswelling
• Generation of light proportional to glucose concentration
• Permanent crosslink cleavage leading to one‑time release
• Electric current generation by glucose oxidation

Correct Answer: Reversible covalent binding to diols causing hydrogel swelling or deswelling

Q15. Which safety consideration is unique to implantable closed‑loop DDS compared to external patches?

• Risk of transdermal irritation
• Device retrieval difficulty, infection risk and long‑term biocompatibility
• Limited drug loading capacity due to surface area
• No need for any regulatory oversight

Correct Answer: Device retrieval difficulty, infection risk and long‑term biocompatibility

Q16. What is the role of pharmacodynamic (PD) modelling in designing feedback‑regulated DDS?

• Estimating sensor durability unrelated to drug effect
• Relating delivered drug concentration to physiological effect to tune controller setpoints
• Predicting only the chemical stability of the formulation
• Ensuring the device has zero cost of goods

Correct Answer: Relating delivered drug concentration to physiological effect to tune controller setpoints

Q17. Which analytical challenge must be addressed when validating a biosensor for use in closed‑loop DDS?

• Ensuring the sensor responds to every biomolecule in blood equally
• Demonstrating accuracy, precision, specificity, stability and calibration over intended lifetime
• Showing that sensor output is intentionally noisy to prevent overcontrol
• Proving that calibration is never required after manufacture

Correct Answer: Demonstrating accuracy, precision, specificity, stability and calibration over intended lifetime

Q18. Which feedback‑regulated DDS design is most appropriate for rapid transient control of a critical analyte?

• Slowly degrading polymer depot with month‑long release
• Fast‑responsive microfluidic pump with real‑time sensing and actuation
• Single use oral tablet with enteric coating
• Nonresponsive implant that relies on passive diffusion

Correct Answer: Fast‑responsive microfluidic pump with real‑time sensing and actuation

Q19. What regulatory aspect is particularly emphasized for feedback‑regulated DDS combining device and drug functions?

• Only the drug component requires oversight; the device is exempt
• Integrated assessment of combination product safety, device software validation and drug stability
• Avoiding any clinical trials to speed approval
• Labeling that omits instructions for use

Correct Answer: Integrated assessment of combination product safety, device software validation and drug stability

Q20. In designing a feedback controller for a DDS, why is sampling frequency of the sensor important?

• Higher sampling always increases battery consumption without benefit
• It determines the controller’s ability to detect and correct rapid analyte changes and avoid aliasing
• Sampling frequency is irrelevant if the drug has a long half‑life
• Lower sampling eliminates the need for control algorithms

Correct Answer: It determines the controller’s ability to detect and correct rapid analyte changes and avoid aliasing

Download